Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Kappa-type opioid receptor | ||
Ligand | BDBM50083926 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1762408 (CHEMBL4197655) | ||
Ki | 0.052000±n/a nM | ||
Citation | Turnaturi, R; Marrazzo, A; Parenti, C; Pasquinucci, L Benzomorphan scaffold for opioid analgesics and pharmacological tools development: A comprehensive review. Eur J Med Chem148:410-422 (2018) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Kappa-type opioid receptor | |||
Name: | Kappa-type opioid receptor | ||
Synonyms: | Kappa Opioid Receptor | OPIATE Kappa | OPRK1 | OPRK_CAVPO | Opiate Kappa 1 | mu/kappa opioid receptor | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 42744.99 | ||
Organism: | Cavia porcellus (domestic guinea pig) | ||
Description: | P41144 | ||
Residue: | 380 | ||
Sequence: |
| ||
BDBM50083926 | |||
n/a | |||
Name | BDBM50083926 | ||
Synonyms: | (6S,11R)-3-Cyclopropylmethyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol | (SSR)-12-Cyclopropylmethyl-13-methyl-12-aza-tricyclo[9.1.1.0*3,8*]trideca-3(8),4,6-trien-6-ol(cyclazocine) | (cyclazocine)2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid | 10-cyclopropylmethyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol(Cyclazocine) | 3-Cyclopropylmethyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol (cyclazocine) | 3-Cyclopropylmethyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol(Cyclazocine) | 3-Cyclopropylmethyl-8-hydroxy-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocinium | 3-Cyclopropylmethyl-8-hydroxy-6,11-dimethyl-3,4,5,6-tetrahydro-2H-2,6-methano-benzo[d]azocin-1-one ((-)cyclazocine) | BDBM50451129 | CHEMBL3085528 | CYCLAZOCINE | ||
Type | Small organic molecule | ||
Emp. Form. | C18H25NO | ||
Mol. Mass. | 271.3972 | ||
SMILES | C[C@H]1[C@H]2Cc3ccc(O)cc3[C@@]1(C)CCN2CC1CC1 |r,TLB:16:15:1:4.10.3| | ||
Structure |